There was a significant difference in concentrations of IDO between the AML group (3.136 ± 1.845 ng/mL) and the control group (1.076 ± 0.369 ng/mL) (p < 0.001; Fig. 4a). The gene discussed is IDO1; the disease is acute myeloid leukemia.